B&TB&TB&T
  • Advertising
  • Campaigns
  • Marketing
  • Media
  • Technology
  • Regulars
    • Agency Scorecards
    • Best of the Best
    • Campaigns of the Month
    • CMO Power List
    • CMOs to Watch
    • Culture Bites
    • Fast 10
    • New Business Winners
    • Spotlight on Sponsors
  • Jobs
  • Awards
    • 30 Under 30
    • B&T Awards
    • Cairns Crocodiles
    • Women In Media
    • Women Leading Tech
Search
Trending topics:
  • Cairns Crocodiles
  • Nine
  • Seven
  • Federal Election
  • AFL
  • Pinterest
  • AI
  • News Corp
  • Cairns Hatchlings
  • NRL
  • Married At First Sight
  • Channel 10
  • Anthony Albanese
  • oOh!Media
  • Thinkerbell
  • WPP
  • ARN
  • TV Ratings
  • Radio Ratings
  • Sports Marketing

  • About
  • Contact
  • Editorial Guidelines
  • Privacy
  • Terms
  • Advertise
© 2025 B&T. The Misfits Media Company Pty Ltd.
Reading: US Pharmaceuticals Raises AIDS Treatment By 4,000 Per Cent, Twitter Explodes
Share
B&TB&T
Subscribe
Search
  • Advertising
  • Campaigns
  • Marketing
  • Media
  • Technology
  • Regulars
    • Agency Scorecards
    • Best of the Best
    • Campaigns of the Month
    • CMO Power List
    • CMOs to Watch
    • Culture Bites
    • Fast 10
    • New Business Winners
    • Spotlight on Sponsors
  • Jobs
  • Awards
    • 30 Under 30
    • B&T Awards
    • Cairns Crocodiles
    • Women In Media
    • Women Leading Tech
Follow US
  • About
  • Contact
  • Editorial Guidelines
  • Privacy
  • Terms
  • Advertise
© 2025 B&T. The Misfits Media Company Pty Ltd.
B&T > Media > US Pharmaceuticals Raises AIDS Treatment By 4,000 Per Cent, Twitter Explodes
Media

US Pharmaceuticals Raises AIDS Treatment By 4,000 Per Cent, Twitter Explodes

Erin M Doyle
Published on: 23rd September 2015 at 11:42 AM
Erin M Doyle
Share
4 Min Read
SHARE

A 32-year old CEO of Turing Pharmaceuticals has copped social media backlash after it was revealed he raised the price of an AIDS drug by 4,000 per cent.

Hedge fund manager Martin Shkreli (pictured above) recently brought the rights to the drug Daraprim, which is used to treat toxoplasmosis, an infection that can cause serious complications in people with weakened immune systems, such as AIDS patients, as well as in babies born to women who became infected during pregnancy.

Turing Pharmaceuticals acquired the drug in August for US$55 million, the company then raised the price of the 63 year old drug from US$13.50 to US$750 per pill.

Shkreli claimed the money from the increase would be used to develop better drug treatment for toxoplasmosis with fewer side effects. Shkreli appeared on CNBC to justify the 4,000 per cent increase:

Twitter wasn’t buying what Shreli was selling:

Martin Shkreli gives me major Lou Bloom vibes in both personality and appearance. They even have the same haircut. pic.twitter.com/84k9xzGKGb

— The Toad Warrior (@KendrickLaMario) September 22, 2015

People like #martinshkreli are all that is evil in this world. And he’s still so young. Scary. Let’s do some good bud http://t.co/PF8pAjklMO — Rich MC (@richmcpherson) September 23, 2015

Funnily enough, #TuringPharmaceuticals fails the Turing Test, as it’s abundantly clear that #MartinShkreli is not human.

— Andrew McNair (@melvillean) September 22, 2015

#MartinShkreli, you deserve all the worst in the world. How someone so greedy and evil can exist outside a Bond film is beyond me

— Steven Garelick (@sleevin_steven) September 21, 2015

Martin Shkreli looks (and acts) like Smeagol from Lord of the Rings. #martinshkreli @cnbc pic.twitter.com/7pXwi7r9wd — Michael Beatrice (@MichaelBeatrice) September 22, 2015

 

#KingOfAllDoucheBags #MartinShkreli I hope he gets a sinus infection and his pharmacy charges him 8.2 million dollars for amoxicillin.

— George Hnasko (@geebee101010) September 21, 2015

Can’t we all just agree that #MartinShkreli has the most punchable face on the internet?

— The Canada Party (@theCanadaParty) September 22, 2015

 

Move over, @realDonaldTrump . Move over ISIS. @MartinShkreli is actually the worst person in the world. — BaeB-Ocho (@DarthJulesy) September 22, 2015

I hope @MartinShkreli doesn’t buy Maruchen next. I couldn’t justify buying a $1,250 bag of ramen. — Bradley Geiser (@therealbradg) September 22, 2015

I’ve purchased the rights to the world’s orange supply. Oranges are now $10,000 each. Also, turns out you need them to live. #martinshkreli — Andrew Hibbard (@andrewhibbard) September 22, 2015

I see he has made his acct private. I’ll just leave these here. #martinshkreli pic.twitter.com/pNkAxPkvuw — Clinton Maddox (@cbmaddox) September 22, 2015

“I’ve seen more spine in jellyfish and more guts in eleven year old kids.” #martinshkreli pic.twitter.com/x8M1BROhx4

— Calamity Jane (@LetoileSan) September 22, 2015

In response to the twitter backlash, Shkreli told CNBC that the price tag would be dropped in the coming weeks. “Yes it is absolutely a reaction — there were mistakes made with respect to helping people understand why we took this action, I think that it makes sense to lower the price in response to the anger that was felt by people,” Shkreli said, 32.

Featured image sourced from NBC News

Join more than 30,000 advertising industry experts
Get all the latest advertising and media news direct to your inbox from B&T.

No related posts.

Share
Erin M Doyle
By Erin M Doyle
Follow:
Erin Doyle is an experienced digital marketing specialist and comms expert.

Latest News

FISHER Taps Grammy-Nominated Producer Chris Lake For Pop-Up Gig in Sydney Via Liquid I.V., TEG, FleishmanHillard, Live Agency & RIFLE
20/05/2025
Cookies May Linger, But Aussie Consumers Are Already Moving On
20/05/2025
Ogilvy Network ANZ Unites Social & Influence Expertise Under Social@Ogilvy Banner
20/05/2025
Customer Vs Employee Value Propositions: The Disconnect & How To Fix It
20/05/2025
//

B&T is Australia’s leading news publication magazine for the advertising, marketing, media and PR industries.

 

B&T is owned by parent company The Misfits Media Company Pty Ltd.

About B&T

  • About
  • Contact
  • Editorial Guidelines
  • Privacy
  • Terms
  • Advertise

Top Categories

  • Advertising
  • Campaigns
  • Marketing
  • Media
  • Opinion
  • Technology
  • TV Ratings

Sign Up for Our Newsletter



B&TB&T
Follow US
© 2025 B&T. The Misfits Media Company Pty Ltd. All Rights Reserved.
Welcome Back!

Sign in to your account

Register Lost your password?